Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora?

Por Quigley, Eamonn M.M.
Publicado em 2009

Microflora Modulation of Motility

Por Quigley, Eamonn M M
Publicado em 2011

Prucalopride: safety, efficacy and potential applications

Por Quigley, Eamonn M. M.
Publicado em 2012

Gut Bacteria in Health and Disease

Por Quigley, Eamonn M. M.
Publicado em 2013

Prokinetics in the Management of Functional Gastrointestinal Disorders

Por Quigley, Eamonn M M
Publicado no J Neurogastroenterol Motil (2015)

The evaluation of gastrointestinal function in diabetic patients

Por Quigley, Eamonn M.M.
Publicado no World J Gastroenterol (1999)

Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?

Por Quigley, Eamonn M. M.
Publicado no Therap Adv Gastroenterol (2016)

Functional Dyspepsia and Nonerosive Reflux Disease: Clinical Interactions and Their Implications

Por Keohane, John, Quigley, Eamonn M.M.
Publicado em 2007

Gastrointestinal Issues in the Assessment and Management of the Obese Patient

Por Hussain, Zulfiqar, Quigley, Eamonn M. M.
Publicado em 2007

Functional dyspepsia: The role of visceral hypersensitivity in its pathogenesis

Por Keohane, John, Quigley, Eamonn M M
Publicado em 2006

An update on prucalopride in the treatment of chronic constipation

Por Omer, Anam, Quigley, Eamonn M.M.
Publicado no Therap Adv Gastroenterol (2017)

The gastrointestinal surgical patient : preoperative and postoperative care /

Por Quigley, Eamonn M. M., Sorrell, Michael F.
Publicado em 1994

Current and Emerging Therapies for the Management of Functional Gastrointestinal Disorders

Por Craig, Orla F., Quigley, Eamonn M. M.
Publicado em 2011

Probiotics, prebiotics & synbiotics in small intestinal bacterial overgrowth: Opening up a new therapeutic horizon!

Por Chen, Wei Chung, Quigley, Eamonn M.M.
Publicado no Indian J Med Res (2014)

Diverticula and Diverticulitis: Time for a Reappraisal

Por Barroso, Alberto O., Quigley, Eamonn M. M.
Publicado no Gastroenterol Hepatol (N Y) (2015)

Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic

Por Charbonneau, Duane, Gibb, Roger D., Quigley, Eamonn M.M.
Publicado em 2013

Irritable Bowel Syndrome: The Role of Food in Pathogenesis and Management

Por Hayes, Paula A., Fraher, Marianne H., Quigley, Eamonn M. M.
Publicado em 2014

The microbiota link to irritable bowel syndrome: An emerging story

Por Jeffery, Ian B., Quigley, Eamonn M. M., Öhman, Lena, Simrén, Magnus, O'Toole, Paul W.
Publicado em 2012

Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort

Por Clarke, Gerard, Fitzgerald, Peter, Cryan, John F, Cassidy, Eugene M, Quigley, Eamonn M, Dinan, Timothy G
Publicado em 2009

The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?

Por Ghoshal, Uday C., Shukla, Ratnakar, Ghoshal, Ujjala, Gwee, Kok-Ann, Ng, Siew C., Quigley, Eamonn M. M.
Publicado em 2012